|
|||||
|
|
| 核苷酸切除修复系统基因多态性与淋巴造血系统肿瘤药物治疗反应的研究进展 | |
| 引用本文： | 廖小莉,刘志辉,李永强. 核苷酸切除修复系统基因多态性与淋巴造血系统肿瘤药物治疗反应的研究进展[J]. 中国肿瘤, 2016, 25(6): 448-452. DOI: 10.11735/j.issn.1004-0242.2016.06.A010 |
| 作者姓名： | 廖小莉 刘志辉 李永强 |
| 作者单位： | 广西医科大学附属肿瘤医院,广西 南宁,530021 |
| 基金项目： | 广西科学基金资助项目（桂科基0342010-7） |
| 摘 要： | 核苷酸切除修复途径是细胞内最主要、最灵活的DNA修复方式.单核苷酸多态性(single nucleotide polymorphisms,SNPs)是人类第三代分子遗传标志物,反映了个体表型、疾病易感性以及对药物、环境等影响因素反应的差异.淋巴造血系统肿瘤是一种多基因遗传疾病,涉及到多个遗传易感基因的相互作用.全文就NER基因多态性与淋巴造血系统肿瘤药物反应性密切关联的相关基因进展作一综述. |
| 关 键 词： | 单核苷酸多态性 淋巴造血系统肿瘤 基因 |
| 收稿时间： | 2016-01-02 |
Association Between Polymorphisms of Nucleotide Excision Repair Genes and Drug Response of Lymphoid Hematopoietic Malignancies |
|
| Affiliation: | Affiliated Tumor Hospital of Guangxi Medical University |
| Abstract: | Abstract：Nucleotide excision repair(NER) is the main and most flexible DNA repair mode in the cells. Single nucleotide polymorphisms(SNPs) are the third generation of human molecular genetic markers，which reflects the diversity in individual phenotype，disease susceptibility and drug response and other environmental factors. Lymphoid hematopoietic malignancies are multi-gene genetic diseases，in which multiple genetic susceptibility genes are involved. This review summaraized the progress on association between polymorphisms NER genes and drug responsiveness of lymphoid hematopoietic malignancies. |
| Keywords: | single nucleotide polymorphisms lymphoid hematopoietic malignancies gene |
| 本文献已被 万方数据 等数据库收录！ | |
| 点击此处可从《中国肿瘤》浏览原始摘要信息 | |
| 点击此处可从《中国肿瘤》下载免费的PDF全文 | |